本次活动由四川省药品监督管理局、成都东部新区管委会联合主办，以"临床驱动，生态赋能，共筑医 疗器械创新转化新高地"为主题，汇聚近200位政、医、学、研、产领域嘉宾，共同搭建高效对接桥梁， 推动一批具有临床价值的创新医疗（002173）器械项目加速落地，标志着川渝地区在构建"临床需求— 研发创新—产业落地—政策支持—金融助力"五位一体的医疗器械创新生态体系上迈出了坚实一步。 活动现场 图片来源：成都东部新区提供 1月31日，医疗器械领先用户社区应用示范暨"春雨行动"临床研究成果转化对接会在成都东部新区未来 医学城举行。 作为成都东部新区生物医药产业发展高地，成都未来医学城以临床医疗应用为创新原点，构建起"医教 研产"一体化创新发展体系，致力于打造一座未来医学创新与探索前沿、医教研产融合与转化典范的生 命健康之城。此次活动既是临床创新成果的集中亮相，也是成都未来医学城"医教研产"协同发展的生动 展现。作为川渝首个"医疗器械领先用户社区应用示范点"，成都未来医学城锚定"西部医疗器械创新高 地"定位，以"立园满园"行动为引领，正持续完善创新转化保障体系，全力破解医疗器械临床研究成果 转化中"不愿转、不敢转、不会转"的 ...

Core Viewpoint - The new East Ba District branch of Capital Medical University Sanbo Brain Hospital is set to officially open on January 26, enhancing regional medical resources and services [1][8]. Group 1: Hospital Overview - The new hospital is located at No. 36 East Ba Middle Road, Chaoyang District, with a total construction area of 63,000 square meters, featuring 480 beds and 13 operating rooms, including advanced surgical facilities [5][12]. - The hospital aims to serve over 100,000 outpatient visits annually, utilizing smart technology to improve patient experience, such as a robotic pharmacy that can sort and deliver medications in approximately 15 seconds [12][14]. Group 2: Services and Specializations - The hospital is designed as a "large specialty, small comprehensive" facility, focusing on neurology while also developing emergency, pediatric neurology, critical care, pain management, rehabilitation, and traditional Chinese medicine departments [16][19]. - The hospital will establish five centers: International Neurological Consultation Center, Brain Health Management Center, Difficult Critical Illness Diagnosis Center, High-end Talent Training Center, and Medical Achievement Transformation Center [19]. Group 3: Community Impact - The East Ba District has a dense population, and the new hospital is expected to meet the local demand for accessible healthcare services, with residents expressing anticipation for its opening [16][19]. - The hospital's strategic location and expanded services aim to address the diverse medical needs of the surrounding community [16][19].

Core Insights - The new campus of Guangming District People's Hospital is expected to begin trial operations by the end of this year, with a total construction area of approximately 340,000 square meters and the capacity to provide 1,500 beds [1] - The hospital aims to enhance the region's emergency and critical care capabilities and contribute to the establishment of an integrated health ecosystem in Guangming Science City [1][2] Group 1 - The new hospital campus is a significant milestone for Guangming District People's Hospital, which has evolved from two rudimentary health posts in 1952 to a comprehensive hospital with over 50 community health centers and an annual patient volume exceeding 4.5 million [1][2] - The hospital has achieved several milestones, including recognition as a national-level chest pain center and heart failure center, and has maintained an A-level quality in medical data [2] - The hospital's innovative "1234" scientific and educational integration system includes the establishment of one national drug trial base, two translational research bases, three scientific and educational platforms, and four talent training bases [2] Group 2 - The opening of the new campus and collaboration with Shenzhen University of Technology will focus on building five critical care centers and seven academic clusters, aiming for breakthroughs in key disciplines at the municipal level [2]

Core Insights - The 42nd National Pharmaceutical Industry Information Annual Conference and the 2025 Beijing-Changping Life Science Forum highlighted the Chengdu Future Medical City as a "model for future medical innovation and transformation" due to its integrated innovation and transformation system in the "medical education research production" sector [1][2] Group 1: Recognition and Achievements - Chengdu Future Medical City was recognized alongside eight other renowned industrial parks from major cities like Beijing, Shanghai, and Shenzhen, marking a significant achievement in national-level recognition for its contributions to technological innovation and results transformation [1] - The park's innovative practices address critical pain points in the biopharmaceutical industry, particularly the disconnect between clinical demand and supply-side capabilities, providing a valuable "Chengdu sample" and "Sichuan experience" for national biopharmaceutical park transformation [1] Group 2: Innovation and Collaboration - During the event, Chengdu Future Medical City launched 14 innovative scenarios across five areas, focusing on the application of new technologies and products, market feedback, user experience, new business models, and pricing mechanisms [2] - The initiative aims to create a diverse testing environment for industrial development, technological innovation, and resource linkage, ultimately facilitating cooperation and market expansion for both local and external enterprises [2] - The city plans to leverage this event as a starting point to deepen clinical demand-oriented translational medical research, accelerate the cultivation of future industries, and enhance the integration of innovation, industry, finance, and talent [2]

Core Viewpoint - The collaboration between Guangdong Pharmaceutical University and Foshan Second People's Hospital aims to establish a high-level hospital and clinical medical college, enhancing healthcare quality and talent development in the region [1][2]. Group 1: Collaboration Agreement - A cooperation agreement was signed to build a new type of affiliated hospital and clinical medical college, focusing on resource sharing and mutual development [1]. - The agreement includes a commitment to invest in clinical specialties and aims to achieve breakthroughs in national and provincial clinical key specialties [1]. Group 2: Talent Development - The partnership will leverage the strengths of Guangdong Pharmaceutical University in clinical medicine and nursing to cultivate high-quality medical talent through specialized programs [1]. - Initiatives such as the "3+2" program and new undergraduate majors will be introduced to support the hospital's academic needs [1]. Group 3: Research Collaboration - The collaboration will utilize the university's research capabilities to address clinical issues, fostering a robust research system within the hospital [1]. - Joint research efforts will be established to produce continuous scientific outcomes, supporting the integrated development of medical education and research [1]. Group 4: Future Development and Innovation - The partnership is seen as a strategic move to enhance both institutions' development and contribute to regional health initiatives [2]. - The focus will be on innovative hospital management and collaborative development mechanisms to improve healthcare delivery and expand influence beyond local services [2]. Group 5: Inauguration of Collaborative Bases - The signing event included the inauguration of several collaborative bases, such as the Third Clinical Medical College and Graduate Training Base of Guangdong Pharmaceutical University [2]. Group 6: Management Capacity Building - A report on modern hospital management was presented, emphasizing the importance of management strategies for high-quality hospital development [3].